The efficacy and safety of systemic corticosteroids as first line treatment for granulomatous lymphocytic interstitial lung disease
Year: 2022
Type: article
Authors: Bas Smits, Sigune Goldacker, Suranjith Seneviratne, Marion Malphettes, Hilary Longhurst, Omar E. Mohamed, Carla Witt-Rautenberg, Lucy Leeman, Eva Schwaneck, Isabelle Raymond, Kilifa Meghit, Annette Uhlmann, Christine Winterhalter, Joris van Montfrans, Marion Klima, Sarita Workman, Claire Fieschi, Lorena Lorenzo, Sonja Boyle, Shamin Onyango-Odera, Suzanne Price, Marc Schmalzing, Valerie Aurillac, Antje Prasse, Ieneke Hartmann, Jennifer J. Meerburg, Mariette Kemner-van de Corput, Harm Tiddens, Bodo Grimbacher, Peter Kelleher, Smita Y. Patel, Anne-Sophie Korganow, Jean-Francois Viallard, Hans-Peter Tony, Claire Bethune, Hendrik Schulze-Koops, Torsten Witte, Aarnoud Huissoon, Helen Baxendale, Sofia Grigoriadou, Eric Oksenhendler, Siobhan O. Burns, Klaus Warnatz
Institutions: University Medical Center Utrecht, Wilhelmina Children's Hospital, University of Freiburg, University Medical Center Freiburg, The Royal Free Hospital, Hôpital Saint-Louis, National Health Service, Barts Health NHS Trust, Royal London Hospital, Heartlands Hospital, Ludwig-Maximilians-Universität München, University Hospitals Plymouth NHS Trust, Asklepios Klinik Altona, Universitätsklinikum Würzburg, Centre Hospitalier Universitaire de Bordeaux, Hôpitaux Universitaires de Strasbourg, Royal Papworth Hospital, Medizinische Hochschule Hannover, German Center for Lung Research, Erasmus MC, Erasmus MC - Sophia Children’s Hospital, German Center for Infection Research, Imperial College London, National Institute for Health and Care Research, University of Oxford, Oxford University Hospitals NHS Trust, Université Paris Cité, University College London
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: green
Awards: G1078610655, G1398522084, G2078056135, G2226533489, G3419571314, Centrum für Chronische Immundefizienz (CCI), G3734007284, G3750362909, G4334920173, EXC 2155: RESIST Resolving Infection Susceptibility, G5186833673, G5276359075, G5365086802, G6160902421, GAIN - Deutsches Netzwerk für die Erforschung und Therapieoptimierung von Patienten mit Multi-Organ-Autoimmunerkrankungen - Teilprojekte Koordination, TP2: Register, TP4:, CTLA4-Insuffizienz, TP5: Immundysregulation aufgrund von Mutationen in NFKB1, TP6: Konsequenzen von STAT3-aktivierenden Mutationen, G6904839380, G7434790516, G7578079922
OpenAlex ID: W4313334451